Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet

Topics

Medicine

Internal Medicine

Endocrinology

Endocrinology, Diabetes And Metabolism

Molecular Biology

Show all topics

DOI

10.1016/s0140-6736(14)60976-4